IVERIC bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IVERIC bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q1 2023.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $11.9M, a 121% increase year-over-year.
  • IVERIC bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $33.2M, a 131% increase year-over-year.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.7M, a 137% increase from 2021.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.2M, a 35.1% increase from 2020.
  • IVERIC bio, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $8.32M, a 9.34% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $33.2M $11.9M +$6.51M +121% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $26.7M $8.35M +$4.1M +96.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $22.6M $6.56M +$3.93M +150% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $18.6M $6.39M +$4.31M +207% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-26
Q1 2022 $14.3M $5.39M +$3.09M +135% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $11.2M $4.25M +$1.97M +86.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $9.28M $2.63M +$779K +42.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $8.5M $2.08M +$206K +11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-26
Q1 2021 $8.29M $2.29M -$32K -1.38% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $8.32M $2.28M -$98K -4.12% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $8.42M $1.85M -$279K -13.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $8.7M $1.87M -$334K -15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $9.03M $2.32M -$146K -5.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.18M $2.38M -$347K -12.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $9.53M $2.13M -$478K -18.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $10M $2.21M -$455K -17.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $10.5M $2.47M -$612K -19.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $11.1M $2.72M -$984K -26.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 $12.1M $2.6M -$807K -23.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $12.9M $2.66M -$2.33M -46.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $15.2M $3.08M -$2.98M -49.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $18.2M $3.71M -$3.06M -45.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $21.2M $3.41M -$4.84M -58.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $26.1M $4.99M -$3.32M -40% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $29.4M $6.06M -$2.27M -27.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $31.7M $6.77M +$485K +7.72% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $31.2M $8.25M +$1.21M +17.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $30M $8.31M +$1.93M +30.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $28M $8.33M +$3.28M +64.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $24.8M $6.29M +$2.74M +77.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $22M $7.04M +$3.46M +96.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $18.6M $6.38M +$3.2M +100% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $15.4M $5.05M +$2.33M +85.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $13M $3.55M +$2.28M +181% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $10.8M $3.58M +$2.43M +212% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $8.32M $3.18M +$2.83M +804% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $5.49M $2.73M +$2.62M +2427% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-07-28
Q4 2013 $2.87M $1.26M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $1.15M +$997K +665% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $352K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $108K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 $150K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.